Atlas Trials

Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)

Clinical trial NCT00883129 · COMPLETED

Trial details

NCT number
NCT00883129
Sponsor
Michael Roth
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
SclerodermaInterstitial Lung Disease
Start date
2009-09-01
Primary completion
2015-01-01
Enrollment
142

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.